Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sex steroid hormone synthesis is the enzymatic process by which cholesterol is converted into biologically active sex steroids: estrogen, androgen, and progestogen hormones. This process involves several key enzymes, including cholesterol side-chain cleavage enzyme (CYP11A1), 17α-hydroxylase/17,20-lyase (CYP17A1), 3β-hydroxysteroid dehydrogenase (HSD3B), 17β-hydroxysteroid dehydrogenase (HSD17B), and aromatase (CYP19). These enzymes catalyze a series of reactions that determine tissue-specific and sex-specific steroid hormone profiles. Many of these enzymes are therapeutic targets in hormone-dependent cancers and endocrine disorders, and their function is essential for sexual differentiation, reproduction, and overall endocrine health[2][4][1]. Drugs targeting these enzymes aim to modulate hormone levels for disease treatment but present significant safety challenges related to the complexity and systemic role of steroid hormones[1][3][4].
Inhibition of biosynthetic enzymes to block sex steroid production (e.g., CYP17A1, CYP19 (aromatase)); Competitive antagonism at the active site; Blocking cholesterol side-chain cleavage
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sex steroid hormone synthesis pathway.